Bone Marrow Aplasia after CAR-T-Cell Therapy for Relapsed/Refractory Burkitt’s Lymphoma

Chimeric antigen receptor T-cells (CAR-T) are now a standard approach for treating relapsed/refractory B-cell lymphomas. Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS) is a newly described entity that can manifest following CAR-T. Bone marrow (BM) aplasia i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kenkel, Troy J., Sridhar, Nithya, Hammons, Lindsay R., Hintzke, Maria, Shah, Nirav N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594436/
https://www.ncbi.nlm.nih.gov/pubmed/37873752
http://dx.doi.org/10.3390/medsci11040067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594436/
https://www.ncbi.nlm.nih.gov/pubmed/37873752
http://dx.doi.org/10.3390/medsci11040067

Ejemplares similares